NCT05138393 Scoliosis-specific Exercises for Mild Idiopathic Scoliosis
| NCT ID | NCT05138393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Idiopathic Scoliosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2022-02-18 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2022-02-18 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Idiopathic scoliosis is the most common spinal deformity in children and adolescents with an estimated prevalence of 3%. About one tenth of the children with scoliosis develop a deformity that requires treatment with brace or surgery with the current treatment protocol. In Sweden, mild scoliosis curves not requiring treatment, but at risk for progression during childhood, are only observed until skeletal maturity without active treatment. If progression occurs and treatment is required, standard treatment consists of bracing 20 hours or more per day. Scoliosis-specific exercises have been reported to be a possible treatment modality in terms of halting progression in mild scoliosis, but the findings are not generally accepted.
Eligibility Criteria
Inclusion Criteria: * Cobb 15-24 degrees * Skeletally immature, Sanders score of 4 or less and Risser \< 2. * No menarche for females * Aged 9-15 years * Apex of the primary curve at T7 or caudal Exclusion Criteria: * Non-idiopathic scoliosis (i.e. neuromuscular, syndromic or congenital scoliosis) * No previous surgical or brace treatment for scoliosis
Contact & Investigator
Elias Diarbakerli, PT, PhD
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT05138393 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 15 Years, studying Idiopathic Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05138393 currently recruiting?
Yes, NCT05138393 is actively recruiting participants. Contact the research team at elias.diarbakerli@regionstockholm.se for enrollment information.
Where is the NCT05138393 trial being conducted?
This trial is being conducted at Linköping, Sweden, Stockholm, Sweden.
Who is sponsoring the NCT05138393 clinical trial?
NCT05138393 is sponsored by Karolinska Institutet. The principal investigator is Elias Diarbakerli, PT, PhD at Karolinska Institutet. The trial plans to enroll 90 participants.